HealthyNCT01290588
Aqueous Humor Dynamics and Biometric Parameters in Eyes of Children
An observational study of Healthy, run by University of Nebraska at 1 site in United States.
Trial summary
The purpose of this study is to determine the effect of age and ethnic background on ocular aqueous humor dynamics and biometric parameters. Data of normal healthy children and adults will be used as controls for future study of juvenile glaucoma, and diabetes and potentially for any other condition that affects… Read more about this study
- Who is it for?
- Ages 15 to 50 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy
- How many people
- 53 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Jun 2013to 25 Mar 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 50 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Study population: * Children * Adults
Who may be able to join
- Subjects must not have any ocular diseases
- Children, 15 - 18 years of age
- Adults, 30 - 50 years of age
Who cannot join
- Women who are pregnant or lactating
- Aphakia or pseudophakia
- Chronic or recurrent severe ocular inflammatory disease.
- Ocular infection or inflammation within three (3) months of screening visit.
- History of clinically significant or progressive retinal disease such as retinal degeneration, diabetic retinopathy or retinal detachment.
- Any abnormality preventing reliable tonometry of either eye.
Show all 15Show fewer
- History of any ocular pathology (including dry eye).
- A cup-to-disc ratio greater than 0.8
- History of intraocular surgery
- History of ocular laser surgery
- History of hypersensitivity or allergy to beta blockers and sulfa drugs.
- History of severe, unstable or uncontrolled cardiovascular, hepatic or renal disease.
- History of bronchial asthma or chronic obstructive pulmonary disease (COPD).
- Inability to discontinue contact lens wear.
- Diagnosis of ocular hypertension or glaucoma or any ocular disease
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Nebraska Medical Center, Department of Ophthalmology and Visual Sciences
Omaha, Nebraska, 68198-5540
About this study
The purpose of this study is to determine the effect of age and ethnic background on ocular aqueous humor dynamics and biometric parameters. Data of normal healthy children and adults will be used as controls for future study of juvenile glaucoma, and diabetes and potentially for any other condition that affects intraocular pressure in children.
Read the detailed description
Glaucoma is a progressive optic neuropathy and a leading cause of blindness in the United States1 and the second leading cause of blindness worldwide. In glaucoma, vision is lost through apoptosis of retinal ganglion cells. Diagnosis of glaucoma is usually based on a combination of progressive, characteristic vision loss (measured using visual field testing) and progressive optic nerve head damage (as detected through dilated fundus examinations or optic disc photography). While ocular hypertension (OHT) is not sufficient for a diagnosis of glaucoma, it is the greatest prognostic and modifiable factor. In fact, the only effective treatment for glaucoma currently is to treat the elevated IOP. This treatment does not provide a cure but it does slow glaucoma progression. IOP is determined by the balance between aqueous production (flow) and aqueous humor outflow through either the trabecular meshwork or uveoscleral pathway. Therefore, all clinically available glaucoma treatments are designed to increase drainage and/or reduce production. The main purpose of the current study is the determination of aqueous humor dynamics.
There are two main types of glaucoma, "open angle" or chronic glaucoma and "closed angle" or acute glaucoma. Open angle glaucoma tends to progress slowly and may remain undetected until the patient notices a change in vision. On the other hand, angle closure glaucoma appears suddenly and can be very painful, therefore is often diagnosed more quickly. The chance of suffering from either one of these types of glaucoma depends greatly on one's ethnic background. People suffering from primary angle-closure glaucoma (PACG) have short axial lengths and shallow anterior chambers. These physical dimensions are found predominantly in people from Asia and India. Angle-closure glaucoma is caused by factors that either pull or push the iris up into the angle, physically blocking the drainage of aqueous humor and increasing the resistance to outflow. The IOP will increase to dangerous levels in order to drain the fluid through the obstructed outflow pathways.
Narrow angles are not present in children. As a person ages, the lens of the eye continues to grow. In some but not all people, this growth pushes the iris forward, narrowing the angle. Risk factors for developing narrow angles include Asian ethnicity, hyperopia, family history, and advanced age. Prevalence figures identify East Asia as home to the majority of those affected by PACG. PACG is acknowledged as a major cause of ocular morbidity in Chinese populations and is more common among Chinese people than among Caucasian people. Part of the global project is to travel to China to study Chinese children and adults. This will be done in collaboration with Ganzu Hospital in Lanzhou, China. This is not part of the current protocol.
Open angle glaucoma typically occurs in older patients in the sixth decade of life or more. African-Americans have up to six times higher risk of developing the condition than the general population especially if there is a family history of glaucoma. Additionally, patients who are highly myopic, have diabetes mellitus, or have cardiovascular problems are at high risk of developing open angle glaucoma. Visual acuity, axial length and medical history will be collected as part of the current protocol.
Unlike narrow angle glaucoma, patients with open angle glaucoma have a gradual blockage of aqueous humor outflow despite a seemingly open chamber angle in the drainage pathway. As the eye ages, the drainage system can become clogged with debris causing pressure inside the eye to build to harmful levels. Open angle glaucoma can develop gradually and remain undetected for years. Because there is usually no pain experienced over the months or years of development and no other symptoms are apparent, the patient is often unaware of the existence of this serious eye disorder. Since African-Americans are at such a high risk for contracting glaucoma, children and adults of this ethnic background will be included in this study.
Glaucoma can occur in children as well as adults. Glaucoma that begins before the child is 3 years old is called infantile or congenital glaucoma. Glaucoma manifesting itself in a child's teens is juvenile glaucoma. There are many causes of childhood glaucoma, such as heredity, or injury or certain eye disorders. Once the investigators collect information on aqueous humor dynamics in healthy teenaged children, the investigators will study children of the same age with glaucoma. The investigators are planning to conduct these studies at Paracelsus University in Salzburg Austria. That is not part of the present protocol.
In the recent rabbit study, the investigators have learned that there are distinctive circadian rhythms of IOP and aqueous humor dynamics in juvenile and adult rabbits. In the ongoing clinical study of ocular hypertensive patients, the investigators are finding that some glaucoma medications are not effective at night despite being efficacious during the day. This has significant clinical importance. The investigators are including the study of aqueous humor dynamics at night in the current protocol to determine the normal circadian patterns for each ethnic group and age group.
In animal studies, the investigators have found that there are several significant differences in aqueous humor dynamics in immature animals compared to adult animals. This is not just a continuum of changes occurring between young and old adults. The investigators predict that important changes also take place in the ocular fluid dynamics of the eye as a child matures. The major changes may occur during puberty. Understanding normal ocular physiology in children will help us to understand the pathological changes taking place in juvenile glaucoma. The clinical importance of this project is immense
- Conditions
- Healthy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Children of Caucasian descent | Healthy children of Caucasian descent. | |
| Adults of Caucasian descent | Healthy adult eyes of Caucasian descent. | |
| Children of African-American descent | Healthy children of African-American descent. | |
| Adults of African-American descent | Healthy adults of African-American descent. |
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Feb 2011 (estimated)
- Study start1 Jun 2013
- Primary completion25 Mar 2022
- Study completion25 Mar 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HealthyStudies of the same condition, open and under way.
- More trials run by University of NebraskaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 53 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Nebraska
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Carol B Toris, PhD, Principal investigator, University of Nebraska
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01290588
- Sponsor's protocol ID
- 0364-09-FB
- Status last verified
- Sep 2023
- First submitted
- 3 Feb 2011
- Last updated
- 29 Sep 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Sep 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Aqueous Humor Dynamics and Biometric Parameters in Eyes of Children
- ClinicalTrials.gov ID
- NCT01290588
- Acronym / sponsor ID
- 0364-09-FB
- Conditions
- Healthy
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 53 participants (actual)
- Lead sponsor
- University of NebraskaUniversity, hospital or other
- Study start
- 1 Jun 2013 (actual)
- Primary completion
- 25 Mar 2022 (actual)
- Study completion
- 25 Mar 2022 (actual)
- First posted
- 7 Feb 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine the effect of age and ethnic background on ocular aqueous humor dynamics and biometric parameters. Data of normal healthy children and adults will be used as controls for future study of juvenile glaucoma, and diabetes and potentially for any other condition that affects intraocular pressure in children.
Detailed description
Glaucoma is a progressive optic neuropathy and a leading cause of blindness in the United States1 and the second leading cause of blindness worldwide. In glaucoma, vision is lost through apoptosis of retinal ganglion cells. Diagnosis of glaucoma is usually based on a combination of progressive, characteristic vision loss (measured using visual field testing) and progressive optic nerve head damage (as detected through dilated fundus examinations or optic disc photography). While ocular hypertension (OHT) is not sufficient for a diagnosis of glaucoma, it is the greatest prognostic and modifiable factor. In fact, the only effective treatment for glaucoma currently is to treat the elevated IOP. This treatment does not provide a cure but it does slow glaucoma progression. IOP is determined by the balance between aqueous production (flow) and aqueous humor outflow through either the trabecular meshwork or uveoscleral pathway. Therefore, all clinically available glaucoma treatments are designed to increase drainage and/or reduce production. The main purpose of the current study is the determination of aqueous humor dynamics.
There are two main types of glaucoma, "open angle" or chronic glaucoma and "closed angle" or acute glaucoma. Open angle glaucoma tends to progress slowly and may remain undetected until the patient notices a change in vision. On the other hand, angle closure glaucoma appears suddenly and can be very painful, therefore is often diagnosed more quickly. The chance of suffering from either one of these types of glaucoma depends greatly on one's ethnic background. People suffering from primary angle-closure glaucoma (PACG) have short axial lengths and shallow anterior chambers. These physical dimensions are found predominantly in people from Asia and India. Angle-closure glaucoma is caused by factors that either pull or push the iris up into the angle, physically blocking the drainage of aqueous humor and increasing the resistance to outflow. The IOP will increase to dangerous levels in order to drain the fluid through the obstructed outflow pathways.
Narrow angles are not present in children. As a person ages, the lens of the eye continues to grow. In some but not all people, this growth pushes the iris forward, narrowing the angle. Risk factors for developing narrow angles include Asian ethnicity, hyperopia, family history, and advanced age. Prevalence figures identify East Asia as home to the majority of those affected by PACG. PACG is acknowledged as a major cause of ocular morbidity in Chinese populations and is more common among Chinese people than among Caucasian people. Part of the global project is to travel to China to study Chinese children and adults. This will be done in collaboration with Ganzu Hospital in Lanzhou, China. This is not part of the current protocol.
Open angle glaucoma typically occurs in older patients in the sixth decade of life or more. African-Americans have up to six times higher risk of developing the condition than the general population especially if there is a family history of glaucoma. Additionally, patients who are highly myopic, have diabetes mellitus, or have cardiovascular problems are at high risk of developing open angle glaucoma. Visual acuity, axial length and medical history will be collected as part of the current protocol.
Unlike narrow angle glaucoma, patients with open angle glaucoma have a gradual blockage of aqueous humor outflow despite a seemingly open chamber angle in the drainage pathway. As the eye ages, the drainage system can become clogged with debris causing pressure inside the eye to build to harmful levels. Open angle glaucoma can develop gradually and remain undetected for years. Because there is usually no pain experienced over the months or years of development and no other symptoms are apparent, the patient is often unaware of the existence of this serious eye disorder. Since African-Americans are at such a high risk for contracting glaucoma, children and adults of this ethnic background will be included in this study.
Glaucoma can occur in children as well as adults. Glaucoma that begins before the child is 3 years old is called infantile or congenital glaucoma. Glaucoma manifesting itself in a child's teens is juvenile glaucoma. There are many causes of childhood glaucoma, such as heredity, or injury or certain eye disorders. Once the investigators collect information on aqueous humor dynamics in healthy teenaged children, the investigators will study children of the same age with glaucoma. The investigators are planning to conduct these studies at Paracelsus University in Salzburg Austria. That is not part of the present protocol.
In the recent rabbit study, the investigators have learned that there are distinctive circadian rhythms of IOP and aqueous humor dynamics in juvenile and adult rabbits. In the ongoing clinical study of ocular hypertensive patients, the investigators are finding that some glaucoma medications are not effective at night despite being efficacious during the day. This has significant clinical importance. The investigators are including the study of aqueous humor dynamics at night in the current protocol to determine the normal circadian patterns for each ethnic group and age group.
In animal studies, the investigators have found that there are several significant differences in aqueous humor dynamics in immature animals compared to adult animals. This is not just a continuum of changes occurring between young and old adults. The investigators predict that important changes also take place in the ocular fluid dynamics of the eye as a child matures. The major changes may occur during puberty. Understanding normal ocular physiology in children will help us to understand the pathological changes taking place in juvenile glaucoma. The clinical importance of this project is immense
Study design
- Observational model
- Cohort
- Time perspective
- Other
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Children of Caucasian descent | – | –Healthy children of Caucasian descent. |
| Adults of Caucasian descent | – | –Healthy adult eyes of Caucasian descent. |
| Children of African-American descent | – | –Healthy children of African-American descent. |
| Adults of African-American descent | – | –Healthy adults of African-American descent. |
Who may qualify
- Ages
- 15 to 50 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
- Study population
- * Children * Adults
Key inclusion criteria (3 listed)
- Subjects must not have any ocular diseases
- Children, 15 - 18 years of age
- Adults, 30 - 50 years of age
Key exclusion criteria (15 listed)
- Women who are pregnant or lactating
- Aphakia or pseudophakia
- Chronic or recurrent severe ocular inflammatory disease.
- Ocular infection or inflammation within three (3) months of screening visit.
- History of clinically significant or progressive retinal disease such as retinal degeneration, diabetic retinopathy or retinal detachment.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Sep 2023.
- Individual participant dataSharing planned: No
Related trials for Healthy
Recruiting
THE EFFECTS OF GAME-BASED EXERCISE PROGRAMS
Physical Activity, Body Image
Not yet recruitingPhase 1
A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants
Atopic Dermatitis
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Not yet recruiting
Neuroergonomic Analysis of a Brain-Computer Interface Device (BCI)
Healthy Volunteers - Male and Female
RecruitingPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Healthy Volunteer, Atopic Dermatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Carol B Toris, PhD principal investigator
University of Nebraska
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Healthy, run by University of Nebraska at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2023.